We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Reckitt Benckiser Group Plc | LSE:RB. | London | Ordinary Share | GB00B24CGK77 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 6,498.00 | 6,502.00 | 6,506.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
16/11/2020 14:35 | This is going in the opposite direction to the covid vaccine news flow - | spacecake | |
11/11/2020 12:00 | CREDIT SUISSE RAISES RECKITT BENCKISER TO 'OUTPERFORM' ('NEUTRAL') PRICE TARGET 7800 (7200) PENCE | philanderer | |
10/11/2020 12:16 | Yes, surprised at the rise here today. I'm holding ULVR and PZC. ESNT at least 10p above the recent placing price today :-) I've got FAN on the watchlist but may have missed the best of the recent rise. | philanderer | |
10/11/2020 12:07 | Hi Phil, expected lower again today. Lookimg to add ULVR fwiw. ESNT looking a bit perkier for you. | essentialinvestor | |
10/11/2020 12:04 | Afternoon EI. Just can't make my mind up on RB. | philanderer | |
10/11/2020 06:17 | £1 Billion?, and the rest. Are those brands on the block to be divested. COVID unwind trade picking up pace on yesterday's news. | essentialinvestor | |
09/11/2020 15:08 | 'Ex-Unilever exec spearheads £1bn bid for Reckitt’s Clearasil' Vindi Banga is spearheading a bid from CD&R for a portfolio of Reckitt Benckiser assets, Sky News learns. | philanderer | |
03/11/2020 11:02 | Yep, they gave the same thing out a couple of weeks ago.. 22nd oct Goldmans neutral tp 7450p 22nd oct Berenberg buy tp 9100p 21st oct DZ Bank buy tp 8800p 21st oct Barclays overweight tp 9600p 21st oct UBS buy tp 8750p 20th oct ++++ update ++++ | philanderer | |
03/11/2020 08:40 | UBS Gave BUY rating yesterday with target of 8750 | bartyb | |
02/11/2020 19:19 | “There is . . Anti-coronavirus measures look set to result in lower rates of cold and flu this winter, which would affect sales of Reckitt’s over-the-counter medicines, a portfolio that includes Mucinex cold and flu medicine. Evidence from Australia and South Africa already pointed to this trend, the company said. | philanderer | |
26/10/2020 07:50 | Bit of a disappointing reaction to last weeks results. Always find it strange how few posts we get on here too, big stable fmcg co that has done well this year, almost zero interest. | dr biotech | |
25/10/2020 06:17 | A mention in the . | skinny | |
21/10/2020 10:22 | UBS RAISES RECKITT BENCKISER PRICE TARGET TO 8,750 (8,600) PENCE - 'BUY' BARCLAYS RAISES RECKITT BENCKISER PRICE TARGET TO 9,600 (9,200) PENCE - 'OVERWEIGHT' DZ BANK RAISES FAIR VALUE FOR RECKITT BENCKISER TO 8,800 (8,750) PENCE | bclissold | |
24/9/2020 09:13 | Can someone please remind me of divi payment date? EDIT: Ignore. Found. Payout 29 Sept. | grabster | |
17/9/2020 18:04 | Any INDV longs on this board who want to learn about the DOJ settlement and how to potentially benefit from derivative demands, message me here. | jgrabar | |
04/9/2020 13:08 | Same here can't see why. No news anywhere. | bclissold | |
04/9/2020 12:47 | Why has this been falling for the last week? I don't see any news. | apollocreed1 | |
26/8/2020 18:19 | The Department of Justice’s (“DOJ”) $600 million civil and criminal settlement against Indivior related to marketing the opioid-addiction-tre These matters seek to enhance corporate governance and go after D&O policies to get funds paid in fines back into corporate coffers. Can also allow for incentive awards to shareholders. Best, Josh jgrabar@grabarlaw.co | jgrabar | |
17/8/2020 09:00 | Investomania this morning The share price prospects of Reckitt Benckiser Group Plc (LON:RB) (RB.L), WM Morrison Supermarkets PLC (LON:MRW) (MRW.L) and British American Tobacco plc (LONLBATS) (BATS.L) are relatively mixed in my view. For instance, Reckitt Benckiser’s share price has surged higher during the Covid-19 pandemic. Demand for its health and hygiene products has increased dramatically, which has boosted its sales and profitability. This rate of growth may normalise in the short run in my view. However, I think the stock has further growth potential. Its investment in online could pay off in the long run, as consumers are likely to further shift their spending towards e-commerce in my opinion. This could allow the business to strengthen its relationship with consumers and build further brand loyalty. Even through Reckitt Benckiser’s share price now has a P/E of around 23, I think it could deliver further capital growth in the long run. For me, it is a quality FTSE 100 business that could be worth a rich valuation. | bclissold | |
31/7/2020 16:02 | Tv no liked today | bclissold | |
07/7/2020 08:01 | Two Lysol Products Made by Reckitt Benckiser Get EPA OK for Use Against SARS-CoV-2 07/07/2020 1:18am Dow Jones News Reckitt Benckiser (LSE:RB.) Intraday Stock Chart Tuesday 7 July 2020 Click Here for more Reckitt Benckiser Charts. By Josh Beckerman Reckitt Benckiser Group PLC's Lysol Disinfectant Spray has received U.S. Environmental Protection Agency approval for use against SARS-CoV-2, the virus that causes Covid-19. The EPA said Monday that its approval of the spray and Lysol Disinfectant Max Cover Mist last week represent its first such approvals of surface disinfectants. The Lysol products, popular with consumers seeking to reduce coronavirus risks, were on the EPA's "List N" of products meeting the criteria for effectiveness. The List N entries for the two items were updated "to show they have now been tested directly against SARS-CoV-2." The EPA said these are the first List N products for which the EPA reviewed laboratory testing data and approved label claims against SARS-CoV-2. Lysol Disinfectant Spray was tested per EPA guidelines and was found to kill the virus at two minutes of use, Reckitt Benckiser said. The spray was also reviewed in a peer-reviewed study of its effectiveness published in the American Journal of Infection Control, the company said. Write to Josh Beckerman at josh.beckerman@wsj.c (END) Dow Jones Newswires July 06, 2020 20:03 ET (00:03 GMT) | maywillow | |
05/6/2020 15:18 | Any updates TA view here?, thanks. Thought the share price might have got a bit ahead of itself. | essentialinvestor | |
14/5/2020 22:38 | and a classic inverse H&S - which I missed | toffeeman |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions